Gengos Andrew - Insider Transactions
Insider Type
individual
Companies
2
Average
50,300
Total Txns
7
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 1 | -1 | 0.00 | 3,515.28 | -3,515.28 |
| 2024 | 0 | 1 | -1 | 0.00 | 719.95 | -719.95 |
| 2025 | 5 | 0 | 5 | 96,365.50 | 0.00 | 96,365.50 |
| Total: | 5 | 2 | 7 | 96,365.50 | 4,235.23 | 92,130.27 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. Common Stock US8808811074 |
3.93 USD |
5,000 Bought |
19,634 USD |
27/06/2025 | 27/06/2025 |
| Terns Pharmaceuticals, Inc. Common Stock US8808811074 |
3.93 USD |
5,000 Bought |
19,650 USD |
27/06/2025 | 27/06/2025 |
| Terns Pharmaceuticals, Inc. Common Stock US8808811074 |
3.75 USD |
5,000 Bought |
18,750 USD |
13/06/2025 | 13/06/2025 |
| Terns Pharmaceuticals, Inc. Common Stock US8808811074 |
3.72 USD |
5,000 Bought |
18,600 USD |
13/06/2025 | 13/06/2025 |
| Terns Pharmaceuticals, Inc. Common Stock US8808811074 |
3.95 USD |
5,000 Bought |
19,733 USD |
13/06/2025 | 16/06/2025 |
| Athira Pharma, Inc. Common Stock US04746L1044 |
0.57 USD |
1,272 Sold |
720 USD |
03/09/2024 | 05/09/2024 |
| Athira Pharma, Inc. Common Stock US04746L1044 |
2.91 USD |
1,208 Sold |
3,515 USD |
04/01/2024 | 05/01/2023 |